NIAID/GSK Ebola Vaccine

NIAID/GSK Ebola Vaccine Overview

Reviewed: October 22, 2014

NIAID/GSK Ebola vaccine is an experimental vaccine being tested by the National Institute of Allergy and Infectious Diseases (NIAID) in a phase I clinical trial designed to test for safety and the ability to generate an immune response.

NIAID will test two versions of the NIAID/GSK vaccine: a bivalent version containing genetic material derived from the Zaire and Sudan Ebola species and a monovalent version derived from genetic material from only the Zaire Ebola species.

The Ebola genetic material contained in the investigational vaccine cannot cause someone to become infected with Ebola.

The initial safety and immunogenicity data from the Phase 1 NIAID/GSK Ebola vaccine trials are expected by late 2014.


    Patient Ratings for

    How was your experience with ?

    First, a little about yourself

    Tell us about yourself in a few words?

    What tips would you provide a friend before taking ?

    What are you taking for?

    Choose one
    • Other

    How long have you been taking it?

    Choose one
    • Less than a week
    • A couple weeks
    • A month or so
    • A few months
    • A year or so
    • Two years or more

    How well did work for you?

    Did you experience many side effects while taking this drug?

    How likely would you be to recommend to a friend?